期刊文献+

不同病程2型糖尿病患者血清胱抑素C水平的变化 被引量:3

Change of serum cystatin C in different course of the diabetes mellitus patients
暂未订购
导出
摘要 目的观察不同病程糖尿病患者血清胱抑素C(CysC)水平的变化,以初步判断血清胱抑素C与糖尿病患者病程之间的关系。方法选取120例糖尿病患者,根据病程不同分为A组(病程<5年)、B组(病程5~10年)和C组(病程>10年),分别测量3组患者身高、体重、腰围、臀围,计算体质指数(BMI)、腰臀比(WHR),测定空腹血糖(FPG)、糖化血红蛋白(HbA1C)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C),血肌酐(Scr)、尿素氮(BUN)、尿酸(UA),血清胱抑素C(CysC)、24 h尿微量白蛋白(24 hMAU),观察各组相关资料的变化。结果 B组UA浓度较A组显著增高,C组Sr、CysC、24 hMAU浓度较B组显著增高(P<0.05),其余指标3组间无显著差异;CysC与病程(r=0.219,P=0.016))及尿蛋白(r=0.375,P=0.000)呈显著相关性。结论 2型糖尿病患者随着病程的延长,血清胱抑素C及24 h尿微量白蛋白明显增高,血清胱抑素C或可作为评价早期糖尿病肾病的指标。 Objective To observe the change of serum cystatin C (CysC) in different course of the dia- betes mellitus patients and preliminarily judge the relationship between serum CysC and the disease course of diabetic patients. Methods One hundred and twenty diabetic patients were divided into group A (less than 5 -year disease course), group B (between 5 and 10 years disease course) and group C (more than 10- year disease course). The height, weight, waistline, hipline, BMI, WHR, FPG, HbA1 C, TG, TC, LDL - C, HDL - C, Scr, BUN, UA, CysC and 24 hMAU among these three groups were detected. Results The serum UA concentration was in group B significantly higher than that in group A. The serum Sr, CysC and 24 hMAU contents in group C were higher than those in group B (P 〈 0.05 ). Single factor line analysis showed that the serum CysC levels were positively corrlated with di- abetes course (r =0. 219,P =0.016) and 24 hMAU (r =0. 375,P =0.000). Conclusion CysC and 24 hMAU increased significantly with the course of disease prolonged and CysC might be used as an e- valuation index of early diabetic nephropathy.
出处 《合肥医学院学报》 2013年第3期233-235,共3页 Journal of Zunyi Medical University
基金 贵州省优秀科技教育人才省长专项资金项目(NO:黔省专合字(2008)110) 贵州省科技合作项目(NO:黔科合区域合[2010]7004)
关键词 血清胱抑素C 糖尿病 2型 病程 cystatin C Diabetes mellitus type2 disease course
  • 相关文献

参考文献10

  • 1唐红梅(综述),姜振伟(综述,廖国林(审校).胱抑素C的临床应用[J].国际检验医学杂志,2011,32(2):216-218. 被引量:56
  • 2徐静,贾爱华,张春虹,王俊宏,丁石梅,龙俊宏.胱抑素C及其他标志物诊断糖尿病肾病效能的比较[J].西安交通大学学报(医学版),2010,31(4):481-483. 被引量:30
  • 3Coil E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment[ J]. Am J Kidney Dis,2000,36( 1 ) :29 -34.
  • 4Fehrman -Ekholm I,Seeberger A,Bjsrk J .,et al. Serum cus- tatin C : a useful marker of kidney function in very old people [J]. Scand J Clin Lab Inwest,39,69(5):606 -611.
  • 5Weinert L S, Prates A B, do Amaral F B, et al. Gender does not influence cystatin C concentrations in healthy vol- unteers [ J ]. Clin Chem Lab Med , 2010,48 ( 3 ) :405 - 408.
  • 6Laterza 0 F,Price C P, Scott M G. Cystain C:an improved estimator of glomemlar filtration rate [ J ]. Clin Chen, 2002,48 (5) :699 - 707.
  • 7Ogawa Y, Goto T, Tamasawa N, et al. Serum custatin C in diabetic patients not only an indicator for renal dysfunc- tion in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy [ J ]. Diabetes Res Clin Pract, 2008,79 ( 2 ) : 357 - 361.
  • 8Rigalleau V, Beauvieux M C, Le Moigne F, et al. Cystatin C improves the diagnosis and stratification of chronic kidney disease,and the estimation of Glomerular filtration rate in diabetes [ J ]. Diabetes Metab ,2008 ,34 (5) 482 - 489.
  • 9Jeon Y K, Kim M R, Huh J E, et al. Cystatin C as an early biomarke of Nephropathy in patients with type 2 diabetes [ J ]. J Korean Med Sci,2011,26 (2) :258 - 263.
  • 10蔡艳,白云霞,张永新.血清Cystatin C在早期糖尿病肾病中的临床研究[J].中国中西医结合肾病杂志,2010,11(6):528-529. 被引量:20

二级参考文献40

共引文献96

同被引文献22

  • 1周琦,李少男,李小鹏,王薇,王治国.临床检验室间质量评价数据中离群值的研究[J].中华检验医学杂志,2007,30(2):214-216. 被引量:14
  • 2Fehrman-Ekholm I,Seeberger A, Bjiorkj, et al. Serum cystatin C.. a useful marker of kidney function in very old people. Scand J Clin Lab Invest, 2009,69 : 606-611.
  • 3Weomegt LS,Prates AB,do Amaral FB, et al. Gender does notinfluence cystatin C concerntrations in healthy volunteers. Clin Chem Ldb Med, 201 O, 48 .. 405-408.
  • 4Choe JY,Park SH,Kim SK. Serum cystatin C is a potential en- dogenous marker for the estimation of renal function in male gout patients with renal impairment. J Korean Med Sei, 2010, 25:42-48.
  • 5Kanwar YS, Wada J, Sum L, et al. Diabetic nephropathy., mech- anisms of renal disease progression. Exp Bio Med(Maywood), 2008,233:4-11.
  • 6Ogawa Y, Goto T,Tzmasawa N, et al. Serum cystatin C in dia- betic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardio- vascular events in patients without nephnopathy. Diabetes Res Clin Pract, 2008,79 .- 357-361.
  • 7Jeon YK,Kim MR, Huh JE, et al. Cystatin C as an early bio- marke of nephropathy in patients with type 2 diabetes. J Kore an Med Sci,2011,26258-263.
  • 8Murussi M,Murussi N,Campagnolo N,et al. Early detection o{ diabetic nephropathy. Arq Bras Endocrinol Metab, 2008, 52: 442-451.
  • 9Niccoli G,Conte M,I)ella Bona R,et al. Cystatin C is associat ed with an increased coronary atherosclerotic burden and a sta- ble plaque phenotype in patients with iscbemic heart disease and normal glomerular iltration rate. Atherosclerosis, 2008, 198..373-380.
  • 10卢德权,张卫良,叶巧国.血清胱抑素C测定在2型糖尿病肾病早期诊断中的临床应用[J].中国医药指南,2013,11(1):402-403. 被引量:8

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部